Biotech companies provide the medical innovations and technological breakthroughs that improve healthcare and can achieve ...

Clinical portfolio strengthened through the in-licensing of phase 3-ready antibiotic ceftibuten-ledaborbactamFosmanogepix second phase 3 study initiated; two phase 3 studies in invasive fungal infecti ...

Allschwil, Switzerland, January 07, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

Lloyd’s Register (LR) and Latsco have successfully completed a proof-of-concept for a new standard in digital class assurance with data-driven surveys. This collaboration aims to demonstrate how ...

Stella Osoba is the Senior Editor of trading and investing at Investopedia. She co-founded and chaired Women in Technical Analysis. She has 15+ years of experience as a financial writer and technical ...

The last time a new class of antibiotics reached the market was nearly three decades ago—but that could soon change, thanks to a discovery by researchers at McMaster University. The discovery of the ...

The first wave of reconceived Carnegie classifications are out, shaking up the listings that have long been a coveted source of prestige for research universities. are out to more fully recognize the ...

The rise of antimicrobial-resistant pathogens has spurred scientists to search far and wide for new drugs. And while many antimicrobial molecules have been discovered in recent years, it’s rare to ...

Antibiotics are a powerful tool in fighting bacterial infections like strep throat, whooping cough or a urinary tract infection. But they can leave the patient with nausea, diarrhea or an upset ...